The Effectiveness of Anti-retroviral Drug Therapy for HIV-1 Is Associated with HIV-1 Proviral DNA Levels and Viral Selection

The effect of combination anti-retroviral therapy regimens on HIV-1 proviral DNA levels in peripheral blond mononuclear cells was examined in 12 HIV-1-positive patients, using endpoint dilution polymerse chain reaction and serial cloning, and sequencing of the gag region of HIV-1. The major clone was defined as the most numerous of 10 analysed clones, and observation periods ranged from 8 months to 32 months (mean 19.7 ′ 10.2 months). In five patients (one with primary-stage HIV-1 infection) receiving three anti-retroviral drugs, HIV-1 RNA reduced to undetectable levels (i.e. ≤ 100 copies/ml). HIV-1 proviral DNA and the number of major clones reduced in four of these patients. HIV-1 RNA levels reduced, but remained detectable. In five other patients. In the two remaining patients (both receiving two rather than three anti-retraviral drugs), HIV-1 RNA levels increased. These results suggest that the population of major clones may be affected when HIV-1 RNA levels reduce following combination regimens of anti-retroviral therapy.